NO954135L - Fiskebukspyttkjertel-sykdomsvirus - Google Patents

Fiskebukspyttkjertel-sykdomsvirus

Info

Publication number: NO954135L
Authority: NO; Norway
Prior art keywords: virus; pancreatic disease; disease virus; fish pancreatic; fish
Prior art date: 1994-10-18

Application number

NO954135A

Other languages

English (en)

Other versions

NO954135D0 (no

NO317547B1 (no

Inventor

Marian F Mcloughlin

Robert Thomas Nelson

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-18

Filing date

1995-10-17

Publication date

1996-04-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO954135(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-18 Priority claimed from GB9420956A external-priority patent/GB9420956D0/en

1995-04-28 Priority claimed from GBGB9508704.5A external-priority patent/GB9508704D0/en

1995-05-10 Priority claimed from GBGB9509425.6A external-priority patent/GB9509425D0/en

1995-10-17 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1995-10-17 Publication of NO954135D0 publication Critical patent/NO954135D0/no

1996-04-19 Publication of NO954135L publication Critical patent/NO954135L/no

2004-11-15 Publication of NO317547B1 publication Critical patent/NO317547B1/no

Links

241000700605 Viruses Species 0.000 title abstract 5
208000016222 Pancreatic disease Diseases 0.000 title abstract 2
241000251468 Actinopterygii Species 0.000 abstract 1
241000277263 Salmo Species 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
231100000676 disease causative agent Toxicity 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000019688 fish Nutrition 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Oncology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Cell Biology (AREA)

NO19954135A 1994-10-18 1995-10-17 Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens. NO317547B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9420956A GB9420956D0 (en)	1994-10-18	1994-10-18	Virus
GBGB9508704.5A GB9508704D0 (en)	1995-04-28	1995-04-28	Virus
GBGB9509425.6A GB9509425D0 (en)	1995-05-10	1995-05-10	"Virus"

Publications (3)

Publication Number	Publication Date
NO954135D0 NO954135D0 (no)	1995-10-17
NO954135L true NO954135L (no)	1996-04-19
NO317547B1 NO317547B1 (no)	2004-11-15

Family

ID=27267435

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19954135A NO317547B1 (no)	1994-10-18	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus, fremgangsmate for diagnostisering av sykdom og for isolering av virus, samt vaksine og diagnostisk reagens.
NO2011024C NO2011024I2 (no)	1994-10-18	2011-10-28	Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2011024C NO2011024I2 (no)	1994-10-18	2011-10-28	Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen

Country Status (9)

Country	Link
US (2)	US5939073A (no)
EP (1)	EP0712926B1 (no)
JP (1)	JP3676449B2 (no)
AT (1)	ATE251667T1 (no)
CA (1)	CA2160764C (no)
DE (1)	DE69531891D1 (no)
DK (1)	DK0712926T3 (no)
NO (2)	NO317547B1 (no)
PT (1)	PT712926E (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0626635B1 (en) *	1993-05-24	2003-03-05	Sun Microsystems, Inc.	Improved graphical user interface with method for interfacing to remote devices
WO1999058639A2 (en) *	1998-05-08	1999-11-18	Akzo Nobel N.V.	Structural proteins of fish pancreatic disease virus and uses thereof
CA2393895A1 (en) *	2001-07-17	2003-01-17	University Of Prince Edward Island	Serological test for isav in fish
US6936256B2 (en) *	2001-08-10	2005-08-30	University Of Maryland Biotechnology Institute	Sub-unit vaccine for infectious pancreatic necrosis virus
AU2004279610B2 (en)	2003-10-07	2010-02-25	Ingrid Dheur	Piscirickettsia salmonis antigens and use thereof
DK179025B1 (da)	2005-09-16	2017-08-28	Intervet Int Bv	Fiskevaccine
NZ578541A (en)	2006-12-22	2012-04-27	Soluciones Biotecnologicas Innovacion Ltda	Dna vaccines for fish
AU2008337440B2 (en)	2007-12-19	2013-05-02	Intervet International B.V.	Vaccine antigens from Piscirickettsia salmonis
NO346489B1 (no) *	2008-02-08	2022-09-05	Pharmaq As	Anvendelse av inaktivert SAV i fremstilling av en vaksine.
NO333242B1 (no) *	2008-02-08	2013-04-15	Pharmaq As	Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
US9139618B2 (en)	2010-12-29	2015-09-22	Intervet Inc.	Salmonid alphavirus protein E2
EP2688587B2 (en)	2011-03-25	2023-08-16	Intervet International B.V.	Salmonid alphavirus vaccine
EP3037823A1 (en)	2014-12-22	2016-06-29	BioMar Group A/S	Method for determining pathological tissue damage and diagnosing infectious disease in fish
KR102163242B1 (ko) *	2018-06-05	2020-10-08	전남대학교산학협력단	무지개송어의 면역글로불린 m에 특이적인 단클론항체 및 이의 용도
NO344938B1 (en)	2018-12-13	2020-07-20	Patogen As	Pancreas Disease Virus Markers
CN113122510A (zh) *	2021-04-12	2021-07-16	中国水产科学研究院黑龙江水产研究所	一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5165925A (en) *	1989-05-02	1992-11-24	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University	Vaccine for immunizing fish against infectious pancreatic necrosis virus

1995
- 1995-10-13 DK DK95202771T patent/DK0712926T3/da active
- 1995-10-13 AT AT95202771T patent/ATE251667T1/de active
- 1995-10-13 PT PT95202771T patent/PT712926E/pt unknown
- 1995-10-13 DE DE69531891T patent/DE69531891D1/de not_active Expired - Lifetime
- 1995-10-13 EP EP95202771A patent/EP0712926B1/en not_active Expired - Lifetime
- 1995-10-17 CA CA002160764A patent/CA2160764C/en not_active Expired - Lifetime
- 1995-10-17 NO NO19954135A patent/NO317547B1/no not_active IP Right Cessation
- 1995-10-18 JP JP27017295A patent/JP3676449B2/ja not_active Expired - Lifetime
- 1995-10-18 US US08/544,681 patent/US5939073A/en not_active Expired - Lifetime
1997
- 1997-05-08 US US08/854,057 patent/US5914260A/en not_active Expired - Lifetime
2011
- 2011-10-28 NO NO2011024C patent/NO2011024I2/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO2011024I2 (no)	2015-09-07
EP0712926A3 (no)	1996-07-03
JP3676449B2 (ja)	2005-07-27
JPH08228770A (ja)	1996-09-10
EP0712926A2 (en)	1996-05-22
NO954135D0 (no)	1995-10-17
NO317547B1 (no)	2004-11-15
CA2160764C (en)	2002-09-03
CA2160764A1 (en)	1996-04-19
ATE251667T1 (de)	2003-10-15
NO2011024I1 (no)	2011-11-14
DE69531891D1 (de)	2003-11-13
PT712926E (pt)	2004-02-27
US5914260A (en)	1999-06-22
EP0712926B1 (en)	2003-10-08
DK0712926T3 (da)	2004-02-09
US5939073A (en)	1999-08-17

Legal Events

Date	Code	Title	Description
2005-12-05	CB	Opposition filed (par. 26,5 patents act)	Effective date: 20050812
2008-10-20	PDP	Decision of opposition (par. 25 patent act)	Free format text: PATENTSTYRETS 1. AVDELINGS AVGJORELSE AV 20060824, HVORVED TIDLIGERE MEDDELT PATENT BLE BESLUTTET OPPRETTHOLDT MOT INNSIGELSE, ER DEN 20080929 STADFESTET AV 2. AVDELING. AVGJORELSEN ER RETTSKRAFTIG.
2011-11-14	SPCF	Filing of supplementary protection certificate	Free format text: PRODUCT NAME: NORVAX COMPACT PD VET.; NAT. REG. NO/DATE: MT NR 10-7431 20110818; FIRST REG. NO/DATE: VM 01708/4551 20110810 Spc suppl protection certif: 2011024 Filing date: 20111028
2014-06-02	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: NORVAX COMPACT PD VET. INJEKSJONVAESKE, EMULSJON INTERVET; NAT. REGISTRATION NO/DATE: MT NR 10-7431 20110818; FIRST REGISTRATION: GB VM 01708/4551 20050606 Spc suppl protection certif: 2011024 Filing date: 20111028 Extension date: 20200606
2015-09-07	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: NORVAX COMPACT PD VET. INJEKSJONSVÆSKE, EMULSJON "INTERVET"; REG.NO/DATE: MT NR 10-7431 2011.08.18; FIRST REG.NO/DATE: VM 01708/4551 2005.06.06 Spc suppl protection certif: 2011024 Filing date: 20111028 Extension date: 20200606
2015-10-26	MK1K	Patent expired

Publication	Publication Date	Title
NO954135D0 (no)	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus
DK0784483T3 (da)	2001-03-26	Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul
EA200401405A1 (ru)	2005-04-28	Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
DE69637914D1 (de)	2009-06-10	Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
DE69536039D1 (de)	2010-02-11	Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DE69939747D1 (de)	2008-11-27	Verfahren von dna-impfung
ATE267258T1 (de)	2004-06-15	Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
DE3888086D1 (de)	1994-04-07	Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
ZA923321B (en)	1993-01-27	Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
ATE237691T1 (de)	2003-05-15	Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
DK0775746T3 (da)	2006-04-03	Vaccine mod fjerkræcoccidiose
WO1999058639A3 (en)	1999-12-29	Structural proteins of fish pancreatic disease virus and uses thereof
HU9200583D0 (en)	1992-05-28	Method for producing el peptides of rubeola
PL307170A1 (en)	1995-05-15	Vaccine against multicellular parasites
BR9801992A (pt)	2000-01-11	Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero.
DE3850933D1 (de)	1994-09-08	Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
EP0839913A3 (en)	1999-06-16	DNA-Based vaccination of fish by immersion
ATE499383T1 (de)	2011-03-15	Eine methode zur herstellung von menschlichem natürlichem interferon-alpha
JPS6471488A (en)	1989-03-16	Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
NO942075L (no)	1994-08-03	Rekombinante virus omfattende kunstig proteolytisk spaltingssete
IS3511A7 (is)	1990-04-13	Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski